Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/58051
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYang J.en
dc.contributor.authorStowasser M.en
dc.contributor.authorFuller P.J.en
dc.contributor.authorShen C.en
dc.contributor.authorGwini S.M.en
dc.date.accessioned2026-04-26T23:40:41Z-
dc.date.available2026-04-26T23:40:41Z-
dc.date.copyright2026-
dc.date.issued2026-04-09en
dc.identifier.citationEndocrine. 91(1) (no pagination), 2026. Article Number: 97. Date of Publication: 01 Dec 2026.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/58051-
dc.description.abstractBackground: Current efforts of increasing diagnosis of primary aldosteronism (PA), a potentially curable but under-diagnosed form of hypertension, have been limited to primary care and specialist clinics, leaving out additional opportunities within healthcare. This study estimated hypertension and PA diagnosis rates during hospital admission. Method(s): Public hospital admissions in Victoria, Australia, between 2007/8 and 2018/19 from patients aged >= 15years were retrospectively analysed to estimate rates of hypertension as principal diagnosis and PA as principal and secondary diagnosis to hypertension. Result(s): There were 27,749,684 admissions identified in the period, with 53.2% females and 68.2% aged >= 50years. Nine in 10,000 had a principal diagnosis of hypertension and 51 hypertensive patients also had PA (0.21%, 95% confidence interval 0.15%-0.26%). Principal diagnosis of PA occurred in 0.31/10,000 admissions, with higher diagnosis among males than females (0.34/10,000 vs. 0.29/10,000 admissions; p-value = 0.019) and highest amongst patients aged 50-59years (0.63/10,000 admissions) compared with 0.23/10,000 and 0.07/10,000 amongst those aged < 40years and >= 70years, respectively. Conclusion(s): Under 1% of patients admitted into hospital had a principal diagnosis of hypertension. Although this number is small, the presentations offer an opportunity for clinicians to test patients for PA. The proportion of hypertensive patients diagnosed with PA during admission was lower than the estimated 15% prevalence among hypertensive individuals, however this also highlights that PA diagnosis can occur in this setting. Future research should explore barriers and facilitators to PA diagnosis when patients are admitted to hospital with hypertension, and develop strategies to support timely diagnosis in this setting.Copyright © The Author(s) 2026.-
dc.publisherSpringer-
dc.relation.ispartofEndocrine-
dc.titleHypertension and primary aldosteronism diagnosis in hospitalized patients: an observation from public hospitals in Victoria, Australia.-
dc.typeArticle-
dc.identifier.affiliationHudson Institute - Centre for Endocrinology and Metabolism-
dc.identifier.affiliationHudson Institute - Centre for Reproductive Health-
dc.identifier.affiliationMonash University - School of Public Health and Preventative Medicine-
dc.identifier.affiliationMonash University - School of Clinical Sciences at Monash Health-
dc.identifier.doihttps://dx.doi.org/10.1007/s12020-026-04562-2-
dc.publisher.placeUnited States-
dc.identifier.pubmedid41801588-
dc.identifier.institution(Yang) Department of Medicine, Monash University, Clayton, VIC, Australiaen
dc.identifier.institution(Gwini) School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australiaen
dc.identifier.institution(Shen) Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australiaen
dc.identifier.institution(Stowasser) Endocrine Hypertension Research Centre, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Australiaen
dc.identifier.institution(Gwini, Fuller, Yang) Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC, Australiaen
dc.identifier.affiliationmh(Gwini) School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australiaen
dc.identifier.affiliationmh(Yang) Department of Medicine, Monash University, Clayton, VIC, Australiaen
dc.identifier.affiliationmh(Gwini, Fuller, Yang) Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC, Australiaen
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptEndocrinology-
Appears in Collections:Articles
Show simple item record

Page view(s)

30
checked on May 26, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.